Organ Dosimetry Through Brehmstrahlung Imaging in Patients Undergoing Y-90 Zevalin Treatment: A Comparison With In-111

被引：0
|
作者：
Mormile, M. [1 ]
D'Ambrosio, L. [1 ]
Arrichiello, C. [1 ]
Squame, E. [1 ]
De Martinis, F. [1 ]
Tommaselli, A. [1 ]
Frigeri, F. [1 ]
Pinto, A. [1 ]
Aloj, L. [1 ]
Lastoria, S. [1 ]
机构：
[1] Fdn Pascale, Ist Nazl Tumori, Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 34 条
  • [1] Analysis of time interval between in-111 Zevalin™ and Y-90 Zevalin™ administration.
    Murray, JL
    Vo, KL
    Emmanouilides, C
    Czuczman, M
    Saleh, MN
    Lynch, JW
    Witzig, TE
    Gordon, LI
    Bartlett, N
    Flinn, IW
    Wiseman, GA
    Schilder, RJ
    Darif, M
    White, CA
    BLOOD, 2002, 100 (11) : 314B - 314B
  • [2] SPECT based Dosimetry for Y-90/In-111 Dotatate Therapy
    Gear, J. I.
    Barker, C.
    Gray, M.
    Chittenden, S.
    Du, Y.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S308 - S308
  • [3] Clinical experience with preparation of In-111 and Y-90 labeled Zevalin: Radiochemical purity assessment
    Zimmer, AM
    Chinn, PC
    Morena, RA
    Wakefield, MD
    Spies, SM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1261 - 1261
  • [4] In-111 pentetreotide fusion imaging in selection of neuroendocrine cancer patients for Y-90 somatostatin analog (Y-90 SMT 487) therapy.
    Hartshorne, MF
    Kvols, LK
    Arata, LK
    Wiest, PW
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 38P - 38P
  • [5] An inter-operator study of the accuracy of Y-90/In-111 DOTATATE dosimetry using an anthropomorphic phantom
    Sanderson, T.
    Gear, J.
    Divoli, A.
    Craig, A.
    Gray, M.
    Murray, I.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S157 - S158
  • [6] Bremsstrahlung Imaging: A Valid Alternative For Dose Estimation In Patients Undergoing 90Y Zevalin Treatment
    Arrichiello, C.
    Mormile, M.
    D'Ambrosio, L.
    De Martinis, F.
    Squame, E.
    Frigeri, F.
    Arcamone, M.
    Aurilio, M.
    Aloj, L.
    Lastoria, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S262 - S262
  • [7] A comparison between absolute and relative dose estimation in patients undergoing 90Y-Zevalin treatment
    Arrichiello, C.
    Mormile, M.
    D'Ambrosio, L.
    De Martinis, F.
    Montanino, V.
    Frigeri, F.
    Arcamone, M.
    Tommaselli, A.
    Aloj, L.
    Lastoria, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S238 - S238
  • [8] Prediction of liver hypertrophy in patients undergoing Y-90 radioembolization treatment
    Hou, Xinchi
    Hadjivassiliou, Anastasia
    Klyuzhin, Ivan
    Benard, Francois
    Liu, David
    Rahmim, Arman
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [9] Detection of Y-90 Extravasation by Bremsstrahlung Imaging for Patients Undergoing Y-90-Ibritumomab Tiuxetan Therapy
    Rhymer, Stephanie M.
    Parker, J. Anthony
    Palmer, Matthew R.
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2010, 38 (04) : 195 - 198
  • [10] Comparison of In-111/Y-90-M170 pharmacokinetics and dosimetry in prostate cancer patients and breast cancer patients on cyclosporin A (CSA).
    DeNardo, SJ
    O'Donnell, RT
    Richman, CM
    Shen, S
    Yuan, A
    Goldstein, DS
    Kukis, DL
    Griffith, IJ
    DeNardo, GL
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 217P - 217P
1234